University of Liverpool
The Liverpool Blood Diseases Biobank (LBDB) is a Research Tissue Bank (RTB). The aim of the LBDB is to store a range of samples from patients with haemic malignancy to further research within this area, or to further enhance the knowledge of the biology of cancer. The LBDB has a large range of samples from patients primarily with chronic lymphocytic leukaemia (CLL), but also includes samples from patients with mantle cell lymphoma (MCL) and other B-cell non-Hodgkin’s lymphomas (B-NHL). The LBDB will begin collecting and storing samples from patients with Acute Myeloid Leukaemia (AML) and multiple myeloma (MM). The main samples stored within the LBDB are cryopreserved peripheral blood mononuclear cells (PBMCs) which have been purified from blood donated by patients.
Contact Information
- Email:
- jslupsky@liverpool.ac.uk
- Telephone:
- +44 (0)151 794 9815
- Address:
-
Sherrington Building
Dept Molecular and Clinical Cancer Medicine
Liverpool
Liverpool
Merseyside
L69 3GA
England
Last Updated: 14/03/2022
Annual Statistics
| Year | Access Requests Received | Access Requests Approved | ||||
|---|---|---|---|---|---|---|
| Internal | External | Commercial | Internal | External | Commercial | |
| 2015 | N/A | N/A | N/A | N/A | N/A | N/A |
| 2016 | N/A | N/A | N/A | N/A | N/A | N/A |
| 2017 | N/A | N/A | N/A | N/A | N/A | N/A |
| 2018 | N/A | N/A | N/A | N/A | N/A | N/A |
| 2019 | N/A | N/A | N/A | N/A | N/A | N/A |
| 2020 | N/A | N/A | N/A | N/A | N/A | N/A |
| 2021 | N/A | N/A | N/A | N/A | N/A | N/A |
| 2022 | N/A | N/A | N/A | N/A | N/A | N/A |
| 2023 | N/A | N/A | N/A | N/A | N/A | N/A |
| 2024 | N/A | N/A | N/A | N/A | N/A | N/A |